Beijing Minhai Biotechnology Co.
Biotechnology company focused on vaccine research, development and manufacturing. Located in the Daxing Biomedical Industrial Base in Beijing. Operates R&D centers, pilot and commercial production lines, analytical quality evaluation platforms, and cold-chain fill-finish capabilities. Pipeline includes multiple conjugate, multivalent and other vaccine candidates at preclinical, clinical and registration stages. The company is developing a large vaccine production and R&D campus with multiple GMP-standard workshops and public service platform functions.
Industries
Nr. of Employees
large (251-1000)
Beijing Minhai Biotechnology Co.
Products
Pneumococcal polysaccharide vaccine (23-valent)
Manufacture and commercial launch of a 23-valent pneumococcal polysaccharide vaccine product.
Rabies vaccine (human diploid cell, lyophilized)
Production line and industrialization project for human diploid cell rabies vaccine (freeze-dried injections) with annual capacity targets described in project disclosures.
Inactivated poliomyelitis vaccine (sIPV, liquid)
Reported liquid inactivated polio vaccine production line and associated capacity in R&D/production building disclosures.
Pneumococcal polysaccharide vaccine (23-valent)
Manufacture and commercial launch of a 23-valent pneumococcal polysaccharide vaccine product.
Rabies vaccine (human diploid cell, lyophilized)
Production line and industrialization project for human diploid cell rabies vaccine (freeze-dried injections) with annual capacity targets described in project disclosures.
Inactivated poliomyelitis vaccine (sIPV, liquid)
Reported liquid inactivated polio vaccine production line and associated capacity in R&D/production building disclosures.
Services
Contract vaccine manufacturing and fill-finish
Commercial-scale production and fill-finish services for multiple vaccine types, including pre-filled syringe workflows.
Cold-chain storage and distribution services
Finished product cold storage and logistics support for vaccine distribution; public notices for entrusted storage and distribution.
R&D campus and shared pilot testing platform
On-site R&D center and shared pilot-scale platforms intended to support external R&D institutions and small- and medium-sized biomedical enterprises.
Contract vaccine manufacturing and fill-finish
Commercial-scale production and fill-finish services for multiple vaccine types, including pre-filled syringe workflows.
Cold-chain storage and distribution services
Finished product cold storage and logistics support for vaccine distribution; public notices for entrusted storage and distribution.
R&D campus and shared pilot testing platform
On-site R&D center and shared pilot-scale platforms intended to support external R&D institutions and small- and medium-sized biomedical enterprises.
Expertise Areas
- Vaccine research and platform development
- Conjugate and multivalent vaccine development
- Clinical development and trial management
- Commercial and pilot-scale vaccine manufacturing
Key Technologies
- Conjugate vaccine production methods
- Recombinant protein vaccine production
- Multivalent vaccine platform design
- Oral vaccine formulation technologies